Key result
Qili Qiangxin capsule combined with western medicine improved clinical efficacy in chronic heart failure compared to western medicine alone (e.g., with metoprolol: RR 1.24; 95% CI 1.14-1.34).
Why the study?
Qili Qiangxin capsule is commonly used for heart failure in China, but its clinical efficacy when combined with western medicine for chronic heart failure required systematic assessment.
Does Qili Qiangxin capsule combined with western medicine improve clinical efficacy in patients with chronic heart failure?
Population
Patients with CHF across 42 included studies
Comparison
Qili Qiangxin capsule combined with western medicine vs western medicine alone
Design
Systematic review and meta-analysis
Authors
Loading...
Supports adjunctive Qili Qiangxin capsule in chronic heart failure; extends meta-analytic evidence for traditional Chinese medicine combinations.
Meta-Analysis
Does Qili Qiangxin capsule combined with western medicine improve clinical efficacy in patients with chronic heart failure?
Relative Risk: 1.24 (95% CI 1.14–1.34)
Qili Qiangxin capsule combined with standard Western medicine may improve clinical efficacy and cardiac function in patients with chronic heart failure, though the evidence is limited by poor study quality.
Xu et al. (2021) conducted a meta-analysis in chronic heart failure. Qili Qiangxin capsule combined with western medicine vs. western medicine alone was evaluated on clinical efficacy (RR 1.24, 95% CI 1.14-1.34). Qili Qiangxin capsule combined with western medicine improved clinical efficacy in chronic heart failure compared to western medicine alone (e.g., with metoprolol: RR 1.24; 95% CI 1.14-1.34).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: